Barclays looks to cash in its iShares chips

Barclays has confirmed it has held discussions with a number of potential buyers over the sale of its profitable exchange-traded funds business, iShares, but says no decision regarding the sale of any assets has been made.

The bank is mulling the sale as a way to boost its capital position as it contemplates joining the UK Treasury’s asset protection program.

The program has so far seen Royal Bank of Scotland and Lloyds Banking Group hand over significant stakes to the UK Government in exchange for state insurance against loss-making assets.

Barclays said the discussions were part of the bank’s practice of “regularly reviewing the group’s portfolio of businesses”.

“Barclays businesses continue to perform well and have had a strong start to 2009,” the bank said in a statement.

Sponsored Content

The bank also confirmed that it was in talks with Treasury and the UK’s Financial Services Authority regarding its potential participation in the Government’s insurance scheme.

Barclays said its decision whether to participate in the scheme, and to what extent, would be based on the “economic merits” to shareholders of doing so.

ETFs were about the only product to see net inflows in 2008, according to Barclays’ ETF and ETP Industry Review for year-end 2008.

Figures from Strategic Insight show global net sales of ETFs during the first 10 month of last year totalled $US187.5 billion, compared to net sales of minus $US256.7 billion for mutual funds. It is understood iShares enjoyed a net inflow of about $90 billion in total last year.

At the end of 2008, the global ETF industry had 1590 ETFs with 2658 listings, assets of $711 billion, from 85 providers on 42 exchanges around the world.

The number of ETFs increased by 36 per cent last year, with 472 new ETFs launched.

iShares is based in San Francisco and is part of Barclays Global Investors (BGI), one of the world’s largest institutional managers with more than $US1.9 trillion in assets under management (at June 2008).

Leave a Comment

Sort content by

Short termism presents opportunities for long-term investors

There is more opportunity to capture value-added returns by focusing on the long-horizon end of the investment spectrum, than join the over-crowded short-horizon end where most investment management is conducted, according to president and chief executive of the Canadian Pension Plan Investment Board (CPPIB), David Denison. mrec4inarticleinline Sponsored Content scnative1 scnative2 scnative3

CalPERS urged to pull back commodities risk

CalPERS’ internal commodities team should enforce a tracking error limit for the portfolio it manages, and prepare to boost headcount and resources as investment opportunities evolve and funds under management grow, the fund’s primary asset consultant, Wilshire Associates, found in a review. mrec4inarticleinline Sponsored Content scnative1 scnative2 scnative3

Corporate US plans expect too much

US corporate defined-benefit plans are still severely underfunded, with an artificially high return expectation contributing to the situation, according to a report of the funding status of 308 US corporate defined benefit plans by Wilshire Consulting. mrec4inarticleinline Sponsored Content scnative1 scnative2 scnative3

Global instos collaborate on measuring water risks

Norges Bank Investment Management is leading a consortium of more than 130 institutions globally in a disclosure project aimed at providing investors with a comprehensive assessment of the water risks of the companies they invest in. mrec4inarticleinline Sponsored Content scnative1 scnative2 scnative3

Wilshire survives and retains CalPERS consulting tender

Wilshire Associates has survived another competitive tender, trumping RogersCasey in the interview scoring process to retain the position of CalPERS’ lead general investment consultant, a position it has held since 1983. mrec4inarticleinline Sponsored Content scnative1 scnative2 scnative3

Pension funds unite: you can double returns

Paul Woolley insists that he is pro market forces; he is not some sort of Trotskyite. A cursory glance at some of the research work he is either doing or financing might prompt scepticism. But this urbane Londoner who established the top-shelf GMO quant shop in Europe is mainly concerned about inefficiencies and mispricing. And

Previous